SCHEMBL3340313

SCHEMBL3340313

Cc1ccc(-n2ccc(=O)[nH]c2=O)cc1C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 3/20 0.46
DDB1 Q16531 1/20 0.46
HCAR1 Q9BXC0 1/20 0.37
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
P2RX7 Q99572 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SIRT3 Q9NTG7 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NNMT P40261 1/20 0.35
BRD4 O60885 1/20 0.34
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346082 0.83 KMT2A (0.44) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL25565822 0.79 CRBN (0.56) CRBNDDB1HCAR1ALDH1A1MAPT
SCHEMBL3340320 0.78 CRBN (0.51) CRBNDDB1HCAR1ALDH1A1MAPT
SCHEMBL3343070 0.78 ALDH1A1 (0.38) ALDH1A1MAPTSMN1; SMN2KMT2AMEN1
SCHEMBL3348732 0.78 P2RX7 (0.58) RAB9ASMN1; SMN2P2RX7KMT2AMEN1
SCHEMBL6522040 0.78 F10 (0.43) ALDH1A1MAPTRAB9ASMN1; SMN2P2RX7
SCHEMBL6524527 0.77 CASP1 (0.40) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL1380326 0.76 CRBN (0.58) CRBNDDB1ALDH1A1MAPTSMN1; SMN2
SCHEMBL23296161 0.75 CRBN (0.51) CRBNDDB1HCAR1ALDH1A1MAPT
SCHEMBL3342210 0.73 ALDH1A1 (0.49) ALDH1A1MAPTKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 CRBN 3855/4885DDB1 2476/4885HCAR1 30/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 CRBN 3110/4885DDB1 1923/4885HCAR1 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.